Elyxium Wealth’s Harmony Biosciences HRMY Stock Holding History

Elyxium Wealth’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.89K	Buy	+99	New	+$3.82K	﹤0.01%	1215

Other funds holding HRMY

CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Sidoxia Capital Management Newport Beach, California $142M AUM

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Pavaki Capital Management Pueblo, Colorado $294M AUM 34.46% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Hedeker Wealth Lincolnshire, Illinois $545M AUM 27.48% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

Elyxium Wealth's HRMY Position: Q3 2026 in Review

Elyxium Wealth opened a new position in Harmony Biosciences (HRMY) in Q3 2026: 99 shares worth $3.89K. The stake represents ﹤0.01% of the portfolio and ranks #1215 among its holdings.

75 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

Elyxium Wealth held 99 shares of Harmony Biosciences worth $3.89K as of Q3 2026.
Harmony Biosciences was a new Elyxium Wealth position in Q3 2026.
Harmony Biosciences made up ﹤0.01% of Elyxium Wealth's portfolio in Q3 2026, its #1215 holding.
75 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on Elyxium Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.